Search
Search Results
-
Anti-Vascular Endothelial Growth Factor (Anti-VEGF) for the Treatment of Type I ROP
This retrospective study evaluated the trends in the use of anti-vascular endothelial growth factor (anti-VEGF) for the treatment of type-1...
-
Publication trends of vascular endothelial growth factor (VEGF) and anti-VEGF treatment in neovascular age-related macular degeneration during 2001–2020: a 20-year bibliometric study
PurposeThis study sought to provide an overview of the current research and further analyze publication trends in the field of vascular endothelial...
-
Langzeitverlauf von makulären Neovaskularisationen bei chorioidalen Osteomen mit und ohne intravitreale Anti-VEGF(vascular endothelial growth factor)-Therapie
BackgroundChoroidal osteoma (CO) is a benign ossifying ocular tumor, which is unilateral in most cases. The CO may cause severe visual impairment,...
-
VEGF-induced Nrdp1 deficiency in vascular endothelial cells promotes cancer metastasis by degrading vascular basement membrane
Vascular endothelial cells (VECs) are key players in the formation of neovessels and tumor metastasis, the ultimate cause of the majority of...
-
Ocular and systemic vascular endothelial growth factor ligand inhibitor use and nephrotoxicity: an update
Tumor growth is intricately linked to the process of angiogenesis, with a key role played by vascular endothelial growth factor (VEGF) and its...
-
Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study
IntroductionPrevious studies have reported controversial relationships between circulating vascular endothelial growth factors (VEGF) and ischemic...
-
Vascular endothelial growth factor in hypersensitivity pneumonitis and connective tissue disease-associated interstitial lung disease
BackgroundA growing evidence on the role of vascular endothelial growth factor (VEGF) in the pathogenesis of interstitial lung diseases accumulated...
-
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic and non-diabetic retinopathy: associated factors and anatomical correlation
BackgroundThis study aims to investigate the factors affecting the vitreous levels of pigment epithelium-derived factor (PEDF) and vascular...
-
Assessment of vascular endothelial growth factor a serum level in pediatric hemophilic arthropathy
BackgroundChildren with hemophilia have serious, recurrent joint bleeding that causes disabilities. Regular factor VIII concentrate replacements have...
-
Expression of endocan and vascular endothelial growth factor and their correlation with histopathological prognostic parameters in pheochromocytoma
ObjectiveEndocan and vascular endothelial growth factor (VEGF) are markers expressed in various cancer types that are highly vascular, and they have...
-
Association of vascular endothelial growth factor serum levels with ankylosing spondylitis in Egyptian patients
BackgroundAnkylosing spondylitis (AS) is one of inflammatory rheumatic diseases which result in wide range of manifestations on the musculoskeletal...
-
Non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy: a systematic review and meta-analysis
BackgroundIntravitreal anti-vascular endothelial growth factor (anti-VEGF) injections play a key role in treating a range of macular diseases. The...
-
Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy
IntroductionAnti-vascular endothelial growth factor (anti-VEGF) injection was widely used in patients with neovascular age-related macular...
-
Relationship between serum fibroblast growth factor 19 and vascular endothelial growth factor and soluble klotho protein in type 1 diabetic children
BackgroundFibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in complications of type 1...
-
Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy
BackgroundThis analysis evaluated aqueous humour (AH) interleukin (IL)-6 concentrations and the association between AH IL-6 and visual outcomes in...
-
Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative Review
The development of treatments targeting the vascular endothelial growth factor (VEGF) signaling pathways have traditionally been firstly investigated...
-
Vascular endothelial growth factor induces the migration of human airway smooth muscle cells by activating the RhoA/ROCK pathway
BackgroundAirway remodeling due to increased airway smooth muscle cell (ASMC) mass, likely due to enhanced proliferation, hypertrophy, and migration,...
-
Chronic sildenafil citrate use decreases retinal vascular endothelial growth factor expression in diabetic rats: a pilot study
BackgroundSildenafil citrate (SC) attenuates endothelial dysfunction. However, its effects on diabetic retinopathy (DR), which is mainly a...
-
TARDBP promotes ovarian cancer progression by altering vascular endothelial growth factor splicing
Disruptions in alternative splicing regulation play an essential role in ovarian cancer progression. However, the underlying mechanism remains...
-
Visual field after anti-vascular endothelial growth factor therapy and laser treatment for retinopathy of prematurity
PurposeTo evaluate the visual field after anti-vascular endothelial growth factor (VEGF) therapy and laser treatment for retinopathy of prematurity.
...